Authors: Bozkurt KK; Department of Pathology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey., Çiriş İM; Department of Pathology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey., Başpınar Ş; Department of Pathology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey., Çetin B; Department of Medical Oncology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey., Erdemoğlu E; Department of Gynecologic Oncology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey., Bircan S; Department of Pathology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey., Ertunç O; Department of Pathology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey.

Source: International journal of surgical pathology [Int J Surg Pathol] 2023 Jun; Vol. 31 (4), pp. 365-374. Date of Electronic Publication: 2022 May 25.

Publication Type: Journal Article

Journal Info: Publisher: Sage Publications Country of Publication: United States NLM ID: 9314927 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1940-2465 (Electronic) Linking ISSN: 10668969 NLM ISO Abbreviation: Int J Surg Pathol Subsets: MEDLINE

Authors: Shi Q; Department of Breast and Thyroid Surgery, Hangzhou Linping District Maternal and child Care Hospital, Hangzhou, China., Yu J; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, 200025, Shanghai, China., Liu D; Department of Breast and Thyroid Surgery, Shanghai General Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China., Ren F; Department of Breast and Thyroid Surgery, Hangzhou Linping District Maternal and child Care Hospital, Hangzhou, China., Wu J; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, 200025, Shanghai, China. pinkscorpio@163.com., Shen K; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, 200025, Shanghai, China. kwshen@medmail.com.cn.

Source: BMC cancer [BMC Cancer] 2023 Feb 21; Vol. 23 (1), pp. 173. Date of Electronic Publication: 2023 Feb 21.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Authors: Toi M; Department of Breast Surgery, Kyoto University Hospital, Kyoto, Japan., Boyle F; Patricia Ritchie Centre for Cancer Care and Research, Mater Hospital, Sydney, Australia.; University of Sydney, Sydney, Australia., Im YH; Division of Hematology/Medical Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Reinisch M; Breast Unit, Kliniken Essen-Mitte, Essen, Germany., Molthrop D; Hematology and Oncology, Florida Cancer Specialists & Research Institute, Orlando, FL, USA., Jiang Z; Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China., Wei R; Lilly Corporate Center, Eli Lilly and Company, Indianapolis, IN, USA., Sapunar F; Lilly Corporate Center, Eli Lilly and Company, Indianapolis, IN, USA., Grimes BR; Lilly Corporate Center, Eli Lilly and Company, Indianapolis, IN, USA., Nabinger SC; Lilly Corporate Center, Eli Lilly and Company, Indianapolis, IN, USA., Johnston SRD; Medical Oncology, Breast Unit, Royal Marsden NHS Foundation Trust, London, UK.

Source: The oncologist [Oncologist] 2023 Jan 18; Vol. 28 (1), pp. e77-e81.

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Authors: Ling AY; Division of Biomedical Informatics Research, Department of Medicine, Quantitative Sciences Unit, Stanford University School of Medicine, Palo Alto, CA, United States of America., Jreich R; Sanofi, Bridgewater, NJ, United States of America., Montez-Rath ME; Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, United States of America., Meng Z; Sanofi, Bridgewater, NJ, United States of America., Kapphahn K; Division of Biomedical Informatics Research, Department of Medicine, Quantitative Sciences Unit, Stanford University School of Medicine, Palo Alto, CA, United States of America., Chandross KJ; Sanofi, Bridgewater, NJ, United States of America., Desai M; Division of Biomedical Informatics Research, Department of Medicine, Quantitative Sciences Unit, Stanford University School of Medicine, Palo Alto, CA, United States of America.

Source: PloS one [PLoS One] 2022 Dec 15; Vol. 17 (12), pp. e0278842. Date of Electronic Publication: 2022 Dec 15 (Print Publication: 2022).

Publication Type: Observational Study; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Authors: Hossain MS; Department of CS, American International University-Bangladesh, Dhaka 1229, Bangladesh.; RIoT Research Center, Independent University, Bangladesh, Dhaka 1229, Bangladesh., Syeed MMM; RIoT Research Center, Independent University, Bangladesh, Dhaka 1229, Bangladesh.; Department of CSE, Independent University, Bangladesh, Dhaka 1229, Bangladesh., Fatema K; RIoT Research Center, Independent University, Bangladesh, Dhaka 1229, Bangladesh.; Department of CSE, Independent University, Bangladesh, Dhaka 1229, Bangladesh., Hossain MS; Department of CS, American International University-Bangladesh, Dhaka 1229, Bangladesh., Uddin MF; RIoT Research Center, Independent University, Bangladesh, Dhaka 1229, Bangladesh.; Department of CSE, Independent University, Bangladesh, Dhaka 1229, Bangladesh.

Source: Sensors (Basel, Switzerland) [Sensors (Basel)] 2022 Sep 28; Vol. 22 (19). Date of Electronic Publication: 2022 Sep 28.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101204366 Publication Model: Electronic Cited Medium: Internet ISSN: 1424-8220 (Electronic) Linking ISSN: 14248220 NLM ISO Abbreviation: Sensors (Basel) Subsets: MEDLINE

Authors: Wang X; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China., Huang Y; Department of Medical Oncology, Chizhou Second People's Hospital, Chizhou, Anhui 247100, China., Yang Z; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China., Yang Y; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China., Wei F; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China., Yan M; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China., Li F; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.

Source: Computational and mathematical methods in medicine [Comput Math Methods Med] 2022 Sep 17; Vol. 2022, pp. 7864114. Date of Electronic Publication: 2022 Sep 17 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Hindawi Country of Publication: United States NLM ID: 101277751 Publication Model: eCollection Cited Medium: Internet ISSN: 1748-6718 (Electronic) Linking ISSN: 1748670X NLM ISO Abbreviation: Comput Math Methods Med Subsets: MEDLINE

Authors: Kattan J; Hôtel-Dieu de France University Hospital, Beirut, Lebanon. jkattan62@hotmail.com.; Saint-Joseph University, Beirut, Lebanon. jkattan62@hotmail.com., Karak FE; Hôtel-Dieu de France University Hospital, Beirut, Lebanon.; Saint-Joseph University, Beirut, Lebanon., Farhat F; Saint-Joseph University, Beirut, Lebanon.; Department of Hematology and Oncology, Hammoud Hospital University Medical Center, Saida, Lebanon., Gerges DA; Department of Hematology and Oncology, Middle East Institute of Health, Bsalim, Lebanon., Mokaddem W; Department of Hematology and Oncology, Haykal Hospital, Tripoli, Lebanon., Chahine G; Hôtel-Dieu de France University Hospital, Beirut, Lebanon.; Saint-Joseph University, Beirut, Lebanon., Khairallah S; National Institute of Pathology, Baabda, Lebanon., Fakhruddin N; Department of Pathology, Hammoud Hospital, Saida, Lebanon., Makarem J; Department of Hematology and Oncology, Ain W Zain Hospital, Ain W Zain, Lebanon., Nasr F; Department of Hematology and Oncology, Mount Lebanon Hospital, Beirut, Lebanon.

Source: BMC cancer [BMC Cancer] 2022 Nov 01; Vol. 22 (1), pp. 1114. Date of Electronic Publication: 2022 Nov 01.

Publication Type: Multicenter Study; Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Authors: Larkin HD

Source: JAMA [JAMA] 2022 Sep 06; Vol. 328 (9), pp. 819.

Publication Type: Journal Article

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

Authors: Yang C; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China., Zhang X; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China., Chen Y; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China., Li P; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China; Guangdong Medical University, Zhanjiang 524000, China., Zhang J; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China., Xu A; School of Medicine, South China University of Technology, Guangzhou University Town, Guangzhou 510006, China., Huang N; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China., Liang M; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China; Shantou University Medical College, Guangdong, China., Chen Y; School of Medicine, South China University of Technology, Guangzhou University Town, Guangzhou 510006, China., Wang K; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China. Electronic address: gzwangkun@126.com.

Source: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2023 May; Vol. 185, pp. 103962. Date of Electronic Publication: 2023 Mar 14.

Publication Type: Meta-Analysis; Journal Article; Review

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

MeSH Terms: Breast Neoplasms*/metabolism , Breast Neoplasms*/mortality , Receptor, ErbB-2*/genetics , Receptor, ErbB-2*/metabolism , Triple Negative Breast Neoplasms*/metabolism , Triple Negative Breast Neoplasms*/mortality, Female ; Humans ; Prognosis ; Proportional Hazards Models

Authors: Li Y; Department of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350000, China; Department of Pathology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350000, China., Tsang JY; Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong., Tam F; Department of Pathology, Kwong Wah Hospital, Hong Kong., Loong T; Department of Pathology, Tuen Mun Hospital, Hong Kong., Tse GM; Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong. Electronic address: garytse@cuhk.edu.hk.

Source: EBioMedicine [EBioMedicine] 2023 May; Vol. 91, pp. 104571. Date of Electronic Publication: 2023 Apr 15.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE

MeSH Terms: Receptor, ErbB-2*/genetics , Receptor, ErbB-2*/metabolism , Breast Neoplasms*/diagnosis , Breast Neoplasms*/genetics , Breast Neoplasms*/therapy, Humans ; Female ; Prognosis ; Biomarkers, Tumor/metabolism

Authors: Fernandez-Martinez A; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.; Department of Genetics, University of North Carolina, Chapel Hill., Pascual T; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; SOLTI Breast Cancer Cooperative Group, Barcelona, Spain., Singh B; Department of Pathology, White Plains Hospital, White Plains, New York., Nuciforo P; Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Rashid NU; Department of Biostatistics, University of North Carolina, Chapel Hill., Ballman KV; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota., Campbell JD; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota., Hoadley KA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.; Department of Genetics, University of North Carolina, Chapel Hill., Spears PA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill., Pare L; Reveal Genomics, Barcelona, Spain., Brasó-Maristany F; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Chic N; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; SOLTI Breast Cancer Cooperative Group, Barcelona, Spain., Krop I; Yale Cancer Center, New Haven, Connecticut., Partridge A; Department of Breast Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Cortés J; International Breast Cancer Center, Barcelona, Spain., Llombart-Cussac A; Medical Oncology Department, Hospital Arnau de Vilanova, Valencia, Spain., Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; SOLTI Breast Cancer Cooperative Group, Barcelona, Spain.; Reveal Genomics, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Breast Cancer Unit, IOB-QuirónSalud, Barcelona, Spain., Perou CM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.; Department of Genetics, University of North Carolina, Chapel Hill., Carey LA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.; Division of Medical Oncology, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill.

Source: JAMA oncology [JAMA Oncol] 2023 Apr 01; Vol. 9 (4), pp. 490-499.

Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

MeSH Terms: Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/immunology , Breast Neoplasms*/pathology , Lymphocytes, Tumor-Infiltrating*/immunology , Receptor, ErbB-2*/genetics , Receptor, ErbB-2*/immunology, Adult ; Female ; Humans ; Middle Aged ; Biomarkers, Tumor/analysis ; Biomarkers, Tumor/immunology ; Immunoglobulin G/immunology ; Lapatinib/therapeutic use ; Neoadjuvant Therapy ; Prognosis ; Transcriptome ; Trastuzumab/therapeutic use ; Treatment Outcome ; Gene Expression Profiling ; Randomized Controlled Trials as Topic ; Paclitaxel/therapeutic use

Authors: Rugo HS; University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Raskina K; Foundation Medicine Inc., Cambridge, Massachusetts., Schrock AB; Foundation Medicine Inc., Cambridge, Massachusetts., Madison RW; Foundation Medicine Inc., Cambridge, Massachusetts., Graf RP; Foundation Medicine Inc., Cambridge, Massachusetts., Sokol ES; Foundation Medicine Inc., Cambridge, Massachusetts., Sivakumar S; Foundation Medicine Inc., Cambridge, Massachusetts., Lee JK; Foundation Medicine Inc., Cambridge, Massachusetts., Fisher V; Foundation Medicine Inc., Cambridge, Massachusetts., Oxnard GR; Foundation Medicine Inc., Cambridge, Massachusetts., Tukachinsky H; Foundation Medicine Inc., Cambridge, Massachusetts.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Mar 14; Vol. 29 (6), pp. 1056-1067.

Publication Type: Editorial; Comment

Journal Info: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

MeSH Terms: Receptor, ErbB-2*/genetics , Receptor, ErbB-2*/therapeutic use , Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology, Humans ; Female ; Fulvestrant/adverse effects ; Mutation ; Class I Phosphatidylinositol 3-Kinases/genetics ; Biology

Authors: Zhao F; Department of Cancer Epigenetics Program, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei, 230031, Anhui, People's Republic of China., Ge F; Department of Provincial Clinical College, Wannan Medical College, Wuhu, 241002, Anhui, People's Republic of China., Xie M; Department of Thoracic Tumor Surgery Department, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei, 230031, Anhui, People's Republic of China., Li Z; Department of Provincial Clinical College, Wannan Medical College, Wuhu, 241002, Anhui, People's Republic of China., Zang C; Department of Radiation Oncology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei, 230031, Anhui, People's Republic of China., Kong L; Department of Anesthesiology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei, 230031, Anhui, People's Republic of China., Pu Y; Department of Cancer Epigenetics Program, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei, 230031, Anhui, People's Republic of China., Zheng X; Department of Head, Neck and Breast Surgery, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei, 230031, Anhui, People's Republic of China. zhengxucai@ustc.edu.cn., Tan Y; Department of Urology Surgery, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei, 230031, Anhui, People's Republic of China. tanyiaoa@ustc.edu.cn.

Source: Clinical & experimental metastasis [Clin Exp Metastasis] 2022 Aug; Vol. 39 (4), pp. 623-639. Date of Electronic Publication: 2022 May 07.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8409970 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7276 (Electronic) Linking ISSN: 02620898 NLM ISO Abbreviation: Clin Exp Metastasis Subsets: MEDLINE

Authors: Catapano C; Institute of Physical and Theoretical Chemistry, Goethe-University Frankfurt, Max-Von-Laue-Str. 7, 60438, Frankfurt, Germany., Rahm JV; Institute of Physical and Theoretical Chemistry, Goethe-University Frankfurt, Max-Von-Laue-Str. 7, 60438, Frankfurt, Germany., Omer M; Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Gustav Wieds Vej 14, 8000, Aarhus C, Denmark.; Center for Cellular Signal Patterns (CellPAT), Aarhus University, Gustav Wieds Vej 14, 8000, Aarhus C, Denmark., Teodori L; Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Gustav Wieds Vej 14, 8000, Aarhus C, Denmark.; Center for Cellular Signal Patterns (CellPAT), Aarhus University, Gustav Wieds Vej 14, 8000, Aarhus C, Denmark., Kjems J; Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Gustav Wieds Vej 14, 8000, Aarhus C, Denmark.; Center for Cellular Signal Patterns (CellPAT), Aarhus University, Gustav Wieds Vej 14, 8000, Aarhus C, Denmark., Dietz MS; Institute of Physical and Theoretical Chemistry, Goethe-University Frankfurt, Max-Von-Laue-Str. 7, 60438, Frankfurt, Germany., Heilemann M; Institute of Physical and Theoretical Chemistry, Goethe-University Frankfurt, Max-Von-Laue-Str. 7, 60438, Frankfurt, Germany. heilemann@chemie.uni-frankfurt.de.

Source: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2023 May 20; Vol. 80 (6), pp. 158. Date of Electronic Publication: 2023 May 20.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-9071 (Electronic) Linking ISSN: 1420682X NLM ISO Abbreviation: Cell Mol Life Sci Subsets: MEDLINE

MeSH Terms: Receptor, ErbB-2*, Ligands ; Cell Proliferation

Authors: Ishiyama N; Black Diamond Therapeutics, Inc., New York, New York., O'Connor M; Black Diamond Therapeutics, Inc., New York, New York., Salomatov A; Black Diamond Therapeutics, Inc., New York, New York., Romashko D; Black Diamond Therapeutics, Inc., New York, New York., Thakur S; Black Diamond Therapeutics, Inc., New York, New York., Mentes A; Black Diamond Therapeutics, Inc., New York, New York., Hopkins JF; Foundation Medicine, Inc., Cambridge, Massachusetts., Frampton GM; Foundation Medicine, Inc., Cambridge, Massachusetts., Albacker LA; Foundation Medicine, Inc., Cambridge, Massachusetts., Kohlmann A; Black Diamond Therapeutics, Inc., New York, New York., Roberts C; Black Diamond Therapeutics, Inc., New York, New York., Buck E; Black Diamond Therapeutics, Inc., New York, New York.

Source: Cancer research [Cancer Res] 2023 May 02; Vol. 83 (9), pp. 1531-1542.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

MeSH Terms: Receptor, ErbB-2*/metabolism , Neoplasms*/genetics, Humans ; Quinazolines/pharmacology ; Allosteric Regulation ; Protein Kinase Inhibitors/pharmacology ; Mutation ; Adenosine Triphosphate

Authors: Liu X; College of Engineering and Applied Sciences, Nanjing University, Jiangsu, 210093, China; Key Laboratory of Intelligent Optical Sensing and Integration of the Ministry of Education, Nanjing University, Jiangsu, 210009, China., Zhu Y; College of Engineering and Applied Sciences, Nanjing University, Jiangsu, 210093, China; Key Laboratory of Intelligent Optical Sensing and Integration of the Ministry of Education, Nanjing University, Jiangsu, 210009, China., Li C; College of Engineering and Applied Sciences, Nanjing University, Jiangsu, 210093, China; Key Laboratory of Intelligent Optical Sensing and Integration of the Ministry of Education, Nanjing University, Jiangsu, 210009, China., Fang Y; School of Chemistry and Chemical Engineering, Nanjing University, Jiangsu, 210093, China., Chen J; Department of Electrical and Electronics Engineer, Southern University of Science and Technology, Shenzhen, 518055, China., Xu F; College of Engineering and Applied Sciences, Nanjing University, Jiangsu, 210093, China., Lu Y; College of Engineering and Applied Sciences, Nanjing University, Jiangsu, 210093, China., Shum PP; Department of Electrical and Electronics Engineer, Southern University of Science and Technology, Shenzhen, 518055, China., Liu Y; School of Chemistry and Chemical Engineering, Nanjing University, Jiangsu, 210093, China. Electronic address: yingliu@nju.edu.cn., Wang G; College of Engineering and Applied Sciences, Nanjing University, Jiangsu, 210093, China; Key Laboratory of Intelligent Optical Sensing and Integration of the Ministry of Education, Nanjing University, Jiangsu, 210009, China. Electronic address: wangguanghui@nju.edu.cn.

Source: Analytica chimica acta [Anal Chim Acta] 2023 Apr 22; Vol. 1251, pp. 340976. Date of Electronic Publication: 2023 Feb 20.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0370534 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4324 (Electronic) Linking ISSN: 00032670 NLM ISO Abbreviation: Anal Chim Acta Subsets: MEDLINE

MeSH Terms: Receptor, ErbB-2*/metabolism , Breast Neoplasms*/diagnosis, Humans ; Female ; Fluorescent Antibody Technique

Authors: Yang J; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China., Shi Z; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China., Zhang X; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China., Liu Q; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China., Cui X; The Department of Pathology of Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China., Li L; The Department of Pathology of Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China., Liu B; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China., Wei J; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China.

Source: Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (8), pp. 9517-9526. Date of Electronic Publication: 2023 Mar 13.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

MeSH Terms: Receptor, ErbB-2*/metabolism , Stomach Neoplasms*/pathology, Humans ; Trastuzumab/adverse effects ; Retrospective Studies ; Esophagogastric Junction/pathology ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

Authors: Hassing CMS; Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Gentofte Hospitalsvej 1, 2900 Hellerup Denmark. Electronic address: christina.marie.schioettz.hassing@regionh.dk., Nielsen DL; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Borgmester Ib Juuls Vej 7, 2730 Herlev, Denmark., Knoop AS; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Section 4262, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark., Tvedskov THF; Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Gentofte Hospitalsvej 1, 2900 Hellerup Denmark., Kroman N; Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Gentofte Hospitalsvej 1, 2900 Hellerup Denmark., Lænkholm AV; Department of Surgical Pathology, Zealand University Hospital, Sygehusvej 9 (postal: Sygehusvej 10), 4000 Roskilde, Denmark., Juhl CB; Department of Physiotherapy and Occupational Therapy, Herlev and Gentofte Hospital, Copenhagen University Hospital, Borgmester Ib Juuls Vej 1, 2730 Herlev, Denmark; Research Unit for Musculoskeletal Function and Physiotherapy, Departments of Sports Science and Clinical Biomechanics, University of Southern Denmark, Campusvej 55, 5230 Odense, Denmark., Kümler I; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Borgmester Ib Juuls Vej 7, 2730 Herlev, Denmark.

Source: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2023 Apr; Vol. 184, pp. 103952. Date of Electronic Publication: 2023 Feb 26.

Publication Type: Meta-Analysis; Systematic Review; Journal Article; Review

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

MeSH Terms: Receptor, ErbB-2* , Breast Neoplasms*/pathology, Humans ; Female ; Trastuzumab/therapeutic use ; Prognosis ; Disease-Free Survival ; Adjuvants, Immunologic ; Chemotherapy, Adjuvant

Authors: Sompuram SR; Boston Cell Standards, Boston MA, USA., Vani K; Boston Cell Standards, Boston MA, USA., Ryan L; Allina Health, Minneapolis, MN, USA., Johnson C; Allina Health, Minneapolis, MN, USA., Szabolcs M; Columbia University Medical Center, New York, NY, USA., Peruyero L; Columbia University Medical Center, New York, NY, USA., Balaton A; Praxea Diagnostics, Massy, France., Pierrot S; Praxea Diagnostics, Massy, France., Joseph L; Lowell General Hospital, Lowell, MA, USA., Pilichowska M; Tufts Medical Center, Boston, MA, USA., Naber S; Tufts Medical Center, Boston, MA, USA., Goldsmith J; Boston Children's Hospital, Boston, MA, USA., Green S; Catholic Medical Center, Manchester, NH, USA., Bogen SA; Boston Cell Standards, Boston MA, USA.

Source: American journal of clinical pathology [Am J Clin Pathol] 2023 Mar 13; Vol. 159 (3), pp. 274-282.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0370470 Publication Model: Print Cited Medium: Internet ISSN: 1943-7722 (Electronic) Linking ISSN: 00029173 NLM ISO Abbreviation: Am J Clin Pathol Subsets: MEDLINE

MeSH Terms: Receptor, ErbB-2*/metabolism , Breast Neoplasms*, Humans ; Female ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism ; Reproducibility of Results ; Epitopes ; Coloring Agents ; Biomarkers, Tumor/metabolism

Authors: Kolbe K; Department of Oncology, Gastroenterology, Hepatology, Pulmonology and Infectious Disease, Leipzig University Medical Center, University Cancer Center Leipzig (UCCL), Leipzig, Germany., Haffner I; Department of Oncology, Gastroenterology, Hepatology, Pulmonology and Infectious Disease, Leipzig University Medical Center, University Cancer Center Leipzig (UCCL), Leipzig, Germany. ivonne.haffner@medizin.uni-leipzig.de., Schierle K; Institute of Pathology, Heilbronn SLK-Kliniken GmbH, Heilbronn, Germany., Maier D; Biomax Informatics AG, 82152, Planegg, Germany., Geier B; Biomax Informatics AG, 82152, Planegg, Germany., Luber B; Institute of Pathology, Technische Universität München, Munich, Germany., Bläker H; Department of Pathology, Leipzig University Medical Center, Leipzig, Germany., Wittekind C; Department of Pathology, Leipzig University Medical Center, Leipzig, Germany., Lordick F; Department of Oncology, Gastroenterology, Hepatology, Pulmonology and Infectious Disease, Leipzig University Medical Center, University Cancer Center Leipzig (UCCL), Leipzig, Germany.

Source: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Mar; Vol. 149 (3), pp. 1319-1329. Date of Electronic Publication: 2022 Aug 27.

Publication Type: Multicenter Study; Journal Article

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

MeSH Terms: Receptor, ErbB-2*/genetics , Stomach Neoplasms*/pathology, Humans ; In Situ Hybridization, Fluorescence/methods ; Prospective Studies ; Trastuzumab ; Biomarkers, Tumor/analysis